Search

Your search keyword '"Muranaka, T."' showing total 709 results

Search Constraints

Start Over You searched for: Author "Muranaka, T." Remove constraint Author: "Muranaka, T."
709 results on '"Muranaka, T."'

Search Results

2. The Compact Linear Collider (CLIC) - 2018 Summary Report

3. Updated baseline for a staged Compact Linear Collider

4. Pressure-induced high-Tc superconducting phase in FeSe: correlation between anion height and Tc

5. AC susceptibility study of superconducting aluminium-doped silicon carbide

6. Specific heat of aluminium-doped superconducting silicon carbide

7. Superconductivity in heavily boron-doped silicon carbide

8. Superconductivity of hexagonal heavily-boron doped silicon carbide

9. Specific heat and electronic states of superconducting boron-doped silicon carbide

10. Soft-phonon-driven superconductivity in CaAlSi as seen by inelastic x-ray scattering

11. The enhancement of superconducting transition temperature in yttrium sesquicarbide system, Y2C3, with the maximum Tc of Tc=18K

12. Evidence for High-frequency Phonon Mediated S-wave Superconductivity : 11B-NMR Study of Al-doped MgB2

13. Manifestation of multiband optical properties of MgB$_2$

14. Micro-Raman scattering investigation of MgB2 and RB2 (R=Al, Mn, Nb and Ti)

15. Bonding Nature in MgB2

16. Electronic structure of MgB$_2$: X-ray emission and absorption studies

17. Optical measurements of the superconducting gap in MgB2

18. High-Resolution Photoemission Study of MgB2

19. Compressibility of the MgB2 Superconductor

20. Evidence for Strong-coupling S-wave Superconductivity in MgB2 :11B NMR Study

21. Potato 14-3-3 St14f

24. 99P Impact of single-heterozygous UGT1A1 on the clinical outcomes of nano-liposomal irinotecan plus 5-fluorouracil/leucovorin for patients with pancreatic ductal adenocarcinoma

29. SO-30 Impact of single-heterozygous UGT1A1 on the clinical outcomes of nano-liposomal irinotecan plus 5-fluorouracil/leucovorin for patients with pancreatic ductal adenocarcinoma

37. P-147 Final analysis: phase II trial of Irinotecan/S-1/cetuximab (IRIS/Cet) as second line treatment in patients with KRAS exon2 wild type mCRC: HGCSG0902. -comparison of administration interval in cetuximab treatment

38. P-152 Observational Cohort Study of 1st line Bevacizumab Combined with Chemotherapy in Metastatic Colorectal Cancer (HGCSG0802): Sub-group Analysis by the Glasgow Prognostic Score (GPS)

48. Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?

49. Flux creep and irreversibility line in superconducting Pb-Bi alloys

Catalog

Books, media, physical & digital resources